Atrium gets rights to Isotechnika's TAFA93, ISA247
- Controlled Release
- Site Specific
- Drug Delivery
- Implantable Devices
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.